[1. N. C. Desai, H. Somani, A. Trivedi, K. Bhatt, L. Nawale, V. M. Khedkar, P. C. Jha and D. Sarkar, Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents, Bioorg. Med. Chem. Lett. 26 (2016) 1776–1783; https://doi.org/10.1016/j.bmcl.2016.02.04310.1016/j.bmcl.2016.02.043]Search in Google Scholar
[2. A. G. Banerjee, N. Das, S. A. Shengule, R. S. Srivastava and S. K. Shrivastava, Synthesis, characterization, evaluation and molecular dynamics studies of 5,6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti–inflammatory and analgesic agents, Eur. J. Med. Chem. 101 (2015) 81–95; https://doi.org/10.1016/j.ejmech.2015.06.02010.1016/j.ejmech.2015.06.020]Search in Google Scholar
[3. W. Wu, Q. Chen, A. Tai, G. Jiang and G. Ouyang, Synthesis and antiviral activity of 2-substituted methylthio-5-(4-amino-2-methylpyrimidin-5-yl)-1,3,4-oxadiazole derivatives, Bioorg. Med. Chem. Lett. 25 (2015) 2243–2246; https://doi.org/10.1016/j.bmcl.2015.02.06910.1016/j.bmcl.2015.02.069]Search in Google Scholar
[4. S. Zhang, Y. Luo, L. Q. He, Z. J. Liu, A. Q. Jiang, Y. H. Yang and H. L. Zhu, Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity, Bioorg. Med. Chem. 21 (2013) 3723–3729; https://doi.org/10.1016/j.bmc.2013.04.04310.1016/j.bmc.2013.04.043]Search in Google Scholar
[5. R. A. Rane, S. D. Gutte and N. U. Sahu, Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent, Bioorg. Med. Chem. Lett. 22 (2012) 6429–6432; https://doi.org/10.1016/j.bmcl.2012.08.06110.1016/j.bmcl.2012.08.061]Search in Google Scholar
[6. Y. Kotaiah, N. Harikrishna, K. Nagaraju and C. V. Rao, Synthesis and antioxidant activity of 1,3,4-oxadiazole tagged thieno[2,3-d]pyrimidine derivatives, Eur. J. Med. Chem. 58 (2012) 340–345; https://doi.org/10.1016/j.ejmech.2012.10.00710.1016/j.ejmech.2012.10.007]Search in Google Scholar
[7. N. C. Desai, N. Bhatt, H. Somani and A. Trivedi, Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles, Eur. J. Med. Chem. 67 (2013) 54–59; https://doi.org/10.1016/j.ejmech.2013.06.02910.1016/j.ejmech.2013.06.029]Search in Google Scholar
[8. M. Mahesh, G. Bheemaraju, G. Manjunath and P. V. Ramana, Synthesis of new oxadiazole, pyrazole and pyrazolin-5-one bearing 2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy) acetohydrazide analogs as potential antibacterial and antifungal agents, Ann. Pharm. Fran. 74 (2016) 34–44; https://doi.org/10.1016/j.pharma.2015.07.00210.1016/j.pharma.2015.07.002]Search in Google Scholar
[9. J. Wu, B. Song, H. Chen, P. Bhadury and D. Hu, Synthesis and antifungal activity of 5-chloro-6-phenylpyridazin-3(2H)-one derivatives, Molecules14 (2009) 3676–3687; https://doi.org/10.3390/molecules1409367610.3390/molecules14093676]Search in Google Scholar
[10. J. D. S. Chaves, L. G. Tunes, C. H. de J. Franco, T. M. Francisco, C. C. Corrêa, S. M. F. Murta, R. L. Monte-Neto, H. Silva, A. P. S. Fontes and M. V. de Almeida, Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents, Eur. J. Med. Chem. 127 (2017) 727–739; https://doi.org/10.1016/j.ejmech.2016.10.05210.1016/j.ejmech.2016.10.052]Search in Google Scholar
[11. P. Puthiyapurayil, B. Poojary, C. Chikkanna and S. K. Buridipad, Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents, Eur. J. Med. Chem. 53 (2012) 203–210; https://doi.org/10.1016/j.ejmech.2012.03.05610.1016/j.ejmech.2012.03.056]Search in Google Scholar
[12. S. Bansal, M. Bala, S. K. Suthar, S. Choudhary, S. Bhattacharya, V. Bhardwaj, S. Singla and A. Joseph, Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity, Eur. J. Med. Chem. 80 (2014) 167–174; https://doi.org/10.1016/j.ejmech.2014.04.04510.1016/j.ejmech.2014.04.045]Search in Google Scholar
[13. S. R. Desai, U. Laddi, R. S. Bennur, P. A. Patil and S. Bennur, Synthesis and pharmacological activities of some new 5-substituted-2-mercapto-1,3,4-oxadiazoles, Indian J. Pharm. Sci. 73 (2011) 593–596; https://doi.org/10.4103/0250-474X.9902510.4103/0250-474X.99025]Search in Google Scholar
[14. E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg and A. Holy, Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines, Antiviral Res. 8 (1987) 261–272; https://doi.org/10.1016/S0166-3542(87)80004-910.1016/S0166-3542(87)80004-9]Search in Google Scholar
[15. K. A. El-Sharkawy, N. N. E. El-Sayed and M. Y. Zaki, Uses of 2-amino-5,6-dihydro-4H-cyclopenta-[b]thiophene-3-carbonitrile in the synthesis of heterocyclic compounds with anticonvulsant, behavioral and CNS antidepressant activities, Int. Res. J. Pure Appl. Chem. 2 (2012) 91–104; https://doi.org/10.9734/IRJPAC/2012/122210.9734/IRJPAC/2012/1222]Search in Google Scholar
[16. M. Albratty, K. A. El-Sharkawy and M. S. Alam, Synthesis and antitumor activity of some novel thiophene, pyrimidine, coumarin, pyrazole and pyridine derivatives, Acta Pharm. 67 (2017) 15–33; https://doi.org/10.1515/acph-2017-000410.1515/acph-2017-0004]Search in Google Scholar